Position in MRNA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$44,764,960
+$28,002,844 QoQ
Shares Held
881,200
+55.0% QoQ
Ownership
0.221%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in MRNA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,764,960 | 881,200 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $16,762,116 | 568,400 | Shares | Sole | 2026-02-12 | |
| 2025-06-30 | $27,697,601 | 1,003,900 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $38,558,835 | 1,360,100 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $42,027,317 | 1,010,758 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $20,737,349 | 310,300 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,200,625 | 85,900 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $11,487,168 | 107,800 | Shares | Sole | 2024-05-13 | |
| 2023-06-30 | $23,898,928 | 196,699 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $51,712,228 | 336,712 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,333,773 | 51,964 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $113,879,598 | 963,041 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $312,004,541 | 2,184,141 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $657,719,686 | 3,818,180 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $465,728,713 | 1,833,722 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $769,621,090 | 1,999,743 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $749,222,920 | 3,188,454 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $214,172,522 | 1,635,529 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $183,107,076 | 1,752,724 | Shares | Sole | 2021-02-10 | |
| 2020-06-30 | $20,251,834 | 315,400 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||